HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gerhild van Echten-Deckert Selected Research

Lymphopenia (Lymphocytopenia)

12/2004Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gerhild van Echten-Deckert Research Topics

Disease

6Neuroblastoma
11/2007 - 08/2002
3Lymphoma (Lymphomas)
08/2010 - 01/2003
2Inflammation (Inflammations)
10/2019 - 09/2006
2Alzheimer Disease (Alzheimer's Disease)
06/2014 - 10/2012
2Reperfusion Injury
01/2013 - 01/2009
2Ischemia
01/2013 - 01/2009
2Ileus
11/2010 - 09/2006
1Neoplasms (Cancer)
12/2021
1Chronic Obstructive Pulmonary Disease (COPD)
01/2021
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2021
1Mental Disorders (Mental Disorder)
01/2020
1Neuroinflammatory Diseases
01/2020
1Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
01/2017
1Death (Near-Death Experience)
04/2014
1Dementia (Dementias)
10/2013
1Insulin Resistance
07/2012
1Multiple Sclerosis
03/2011
1Inborn Genetic Diseases (Disease, Hereditary)
04/2008
1Neurodegenerative Diseases (Neurodegenerative Disease)
04/2008
1Oncogene Addiction
02/2008
1Lymphopenia (Lymphocytopenia)
12/2004
1Burkitt Lymphoma (Burkitt's Lymphoma)
01/2003

Drug/Important Bio-Agent (IBA)

8SphingolipidsIBA
12/2021 - 09/2006
5Proteins (Proteins, Gene)FDA Link
06/2014 - 08/2002
4sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
10/2019 - 12/2002
3SphingosineIBA
01/2017 - 12/2002
2ectoineIBA
01/2021 - 01/2013
2LipidsIBA
01/2020 - 04/2008
2Amyloid (Amyloid Fibrils)IBA
06/2014 - 10/2012
2Fingolimod Hydrochloride (FTY720)FDA Link
03/2011 - 12/2004
2Tyrosine (L-Tyrosine)FDA Link
08/2010 - 02/2008
2Phosphotransferases (Kinase)IBA
08/2010 - 02/2008
1CytokinesIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2020
1sphingosine 1-phosphate lyase (aldolase)IBA
01/2017
1CholesterolIBA
01/2017
1LyasesIBA
01/2017
1hydroxyectoineIBA
04/2014
1dicarboxydine (DCD)IBA
04/2014
1Flavin-Adenine Dinucleotide (FAD)IBA
10/2013
1Peptides (Polypeptides)IBA
10/2012
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
10/2012
1Membrane LipidsIBA
10/2012
1AdipokinesIBA
07/2012
1Fatty Acids (Saturated Fatty Acids)IBA
07/2012
1Pharmaceutical PreparationsIBA
03/2011
1Sphingosine-1-Phosphate ReceptorsIBA
03/2011
1EnzymesIBA
08/2010
1Anaplastic Lymphoma KinaseIBA
08/2010
1Transcription Factors (Transcription Factor)IBA
08/2010
1GlycosphingolipidsIBA
08/2010
1Carboxylic AcidsIBA
01/2009
1GangliosidesIBA
04/2008
1GlycosyltransferasesIBA
04/2008
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
02/2008
1TrichothecenesIBA
11/2007
1Messenger RNA (mRNA)IBA
11/2007
1ProdrugsIBA
12/2004
1Immunosuppressive Agents (Immunosuppressants)IBA
12/2004
1safingol (sphinganine)IBA
09/2003
1erythro-dihydrosphingosineIBA
09/2003
11-methylthiodihydroceramideIBA
03/2003
1SodiumIBA
03/2003
1polyacrylamideIBA
03/2003
1Rituximab (Mabthera)FDA Link
01/2003
1Mitogen-Activated Protein KinasesIBA
12/2002
1Phosphates (Orthophosphate)IBA
12/2002
1CeramidesIBA
08/2002

Therapy/Procedure

2Transplantation
01/2013 - 01/2009
1Organ Transplantation
01/2021
1Aftercare (After-Treatment)
12/2002